Search for: "Janssen Ortho, Inc." Results 61 - 80 of 110
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2010, 4:47 pm
(Patent Docs) Opana (Oxymorphone) – US: Endo files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Ortho Tri-Cyclen Lo (Ethinyl estradiol, norgestimate) – US:Patent infringement complaint filed in New Jersey following a Paragraph IV certification: Ortho-McNeil-Janssen Pharmaceuticals, Inc. v. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
22 Aug 2009, 11:03 pm
MANUFACTURER: Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
13 Sep 2012, 6:48 pm
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been the defendant in numerous Levaquin injury lawsuits over has tendon ruptures and permanent tendon damage. [read post]
18 Jan 2016, 5:00 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F.3d 281 (6th Cir. 2015) – preemption, but not involving generic drugs − which aptly described pre-approval theories as “never-start selling” claims (id. at 300), describes that other decision. [read post]
28 Jun 2010, 3:50 am by Steve McConnell
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2181 (Phila. [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
2 Feb 2010, 7:28 am by Beck, et al.
N.J. 1981) (label change); Janssen Pharmaceutica, Inc. v. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape Pirate Party,… [read post]
5 Jul 2020, 7:58 pm by Omar Ha-Redeye
They concluded that the Deputy Judge’s reliance on Janssen-Ortho Inc. [read post]
10 Jun 2009, 10:00 pm
Janssen Pharmaceutica, Inc., 1997 WL 201571, at *9 (N.D. [read post]
22 Apr 2016, 12:51 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. 3d 281 (6th Cir. 2015); In re Celexa & Lexapro Marketing & Sales Practices Litigation, 779 F.3d 34 (1st Cir. 2015).Now there are three, and the latest is the most a fortiori of the lot.The Third Circuit has applied the Mensing/Bartlettimpossibility preemption rationale outside of the FDCA altogether, to preemption of design defect claims involving airplanes. [read post]
5 Feb 2012, 9:00 pm by Stephanie Figueroa
(now known as Janssen Biotech, Inc.) won against Abbott Laboratories in a dispute over Abbott's arthritis drug Humira. [read post]
5 Feb 2012, 9:00 pm by Stephanie Figueroa
(now known as Janssen Biotech, Inc.) won against Abbott Laboratories in a dispute over Abbott's arthritis drug Humira. [read post]